Electrocardiographic abnormalities attributable to infiltrative cardiomyopathies: review and prevalence in patients with congestive heart failure

The electrocardiogram (ECG) is routinely used in patients with suspected infiltrative cardiomyopathies; heart diseases characterized by the abnormal deposition of pathological substances in the myocardium. This study presents a review of ECG features attributable to various infiltrative cardiomyopat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical research in cardiology 2024-10
Hauptverfasser: Mustafa, Mohammed, White, Casey, Harris, Erin, Tawfellos, George, Oredegbe, Al-Ameen, Torosoff, Mikhail
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Clinical research in cardiology
container_volume
creator Mustafa, Mohammed
White, Casey
Harris, Erin
Tawfellos, George
Oredegbe, Al-Ameen
Torosoff, Mikhail
description The electrocardiogram (ECG) is routinely used in patients with suspected infiltrative cardiomyopathies; heart diseases characterized by the abnormal deposition of pathological substances in the myocardium. This study presents a review of ECG features attributable to various infiltrative cardiomyopathies and analyzes the prevalence and overlap of electrocardiographic abnormalities in patients with adjudicated CHF. The study included 573 consecutive CHF patients without severe aortic stenosis, further stratified by LV hypertrophy (LVH) and preserved or decreased LV ejection fraction. Comprehensive ECG analysis revealed at least one ECG abnormality typically associated with infiltrative cardiomyopathies in 95% of patients, and more than one ECG abnormality in 70%. An average number of ECG abnormalities was 2.2 ± 1.2 per patient. There was substantial overlap in ECG abnormalities in individual patients, particularly those attributable to Fabry's disease and hemochromatosis (51.5%) or cardiac amyloidosis (46.1%), and hemochromatosis and cardiac amyloidosis (44.2%). Prevalence of various ECG abnormalities was similar across various patient demographics and co-morbidities, including LVH status and/or history of CAD which did not increase the number of ECG abnormalities (2.155 ± 1.238 vs. 2.228 ± 1.192 in patients without CAD history, p = 0.969). Patients with reduced LV ejection fraction had a higher prevalence of widened QRS and premature ventricular complexes. ECG abnormalities attributable to infiltrative cardiomyopathies are common in heart failure patients, with a significant overlap in findings classically attributed to various infiltrative cardiomyopathies. The presence of LVH and decreased LV ejection fraction do not significantly affect the prevalence of ECG abnormalities.
doi_str_mv 10.1007/s00392-024-02568-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3121589442</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3121589442</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1351-7aa3889a68a7b59f6949d13437067921c45b3233d8004e4723180f83b9057ee73</originalsourceid><addsrcrecordid>eNo9kctO3jAQhS1Exa28AAvkJZuAb0lsdhWiBQmJTbu2Js6E38iJg-2AeAzemMBPWYzmLL5zNJpDyAln55yx9iIzJo2omFDr1I2uxA454LrhFWuM2P3WWu2Tw5wfGas5k2qP7Eujmkap-oC8XQd0JUUHqffxIcG88Y5CN8U0QvDFY6ZQSvLdUqALSEukfhp8KAmKf0a6NY6vcYayWelLmvDZ4wuFqafzqiHg5HA10ZXwOJVMX3zZUBenB8yfGRuEVOgAPiwJf5IfA4SMx1_7iPz7ff336qa6u_9ze_XrrnJc1rxqAaTWBhoNbVeboTHK9Fwq2bKmNYI7VXdSSNlrxhSqVkiu2aBlZ1jdIrbyiJxtc-cUn5b1Ejv67DAEmDAu2UoueK2NUmJFxRZ1KeaccLBz8iOkV8uZ_ajCbquwaxX2swr7YTr9yl-6Eftvy__fy3cERodK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3121589442</pqid></control><display><type>article</type><title>Electrocardiographic abnormalities attributable to infiltrative cardiomyopathies: review and prevalence in patients with congestive heart failure</title><source>SpringerNature Journals</source><creator>Mustafa, Mohammed ; White, Casey ; Harris, Erin ; Tawfellos, George ; Oredegbe, Al-Ameen ; Torosoff, Mikhail</creator><creatorcontrib>Mustafa, Mohammed ; White, Casey ; Harris, Erin ; Tawfellos, George ; Oredegbe, Al-Ameen ; Torosoff, Mikhail</creatorcontrib><description>The electrocardiogram (ECG) is routinely used in patients with suspected infiltrative cardiomyopathies; heart diseases characterized by the abnormal deposition of pathological substances in the myocardium. This study presents a review of ECG features attributable to various infiltrative cardiomyopathies and analyzes the prevalence and overlap of electrocardiographic abnormalities in patients with adjudicated CHF. The study included 573 consecutive CHF patients without severe aortic stenosis, further stratified by LV hypertrophy (LVH) and preserved or decreased LV ejection fraction. Comprehensive ECG analysis revealed at least one ECG abnormality typically associated with infiltrative cardiomyopathies in 95% of patients, and more than one ECG abnormality in 70%. An average number of ECG abnormalities was 2.2 ± 1.2 per patient. There was substantial overlap in ECG abnormalities in individual patients, particularly those attributable to Fabry's disease and hemochromatosis (51.5%) or cardiac amyloidosis (46.1%), and hemochromatosis and cardiac amyloidosis (44.2%). Prevalence of various ECG abnormalities was similar across various patient demographics and co-morbidities, including LVH status and/or history of CAD which did not increase the number of ECG abnormalities (2.155 ± 1.238 vs. 2.228 ± 1.192 in patients without CAD history, p = 0.969). Patients with reduced LV ejection fraction had a higher prevalence of widened QRS and premature ventricular complexes. ECG abnormalities attributable to infiltrative cardiomyopathies are common in heart failure patients, with a significant overlap in findings classically attributed to various infiltrative cardiomyopathies. The presence of LVH and decreased LV ejection fraction do not significantly affect the prevalence of ECG abnormalities.</description><identifier>ISSN: 1861-0684</identifier><identifier>ISSN: 1861-0692</identifier><identifier>EISSN: 1861-0692</identifier><identifier>DOI: 10.1007/s00392-024-02568-2</identifier><identifier>PMID: 39466445</identifier><language>eng</language><publisher>Germany</publisher><ispartof>Clinical research in cardiology, 2024-10</ispartof><rights>2024. Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1351-7aa3889a68a7b59f6949d13437067921c45b3233d8004e4723180f83b9057ee73</cites><orcidid>0000-0002-2587-2302</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39466445$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mustafa, Mohammed</creatorcontrib><creatorcontrib>White, Casey</creatorcontrib><creatorcontrib>Harris, Erin</creatorcontrib><creatorcontrib>Tawfellos, George</creatorcontrib><creatorcontrib>Oredegbe, Al-Ameen</creatorcontrib><creatorcontrib>Torosoff, Mikhail</creatorcontrib><title>Electrocardiographic abnormalities attributable to infiltrative cardiomyopathies: review and prevalence in patients with congestive heart failure</title><title>Clinical research in cardiology</title><addtitle>Clin Res Cardiol</addtitle><description>The electrocardiogram (ECG) is routinely used in patients with suspected infiltrative cardiomyopathies; heart diseases characterized by the abnormal deposition of pathological substances in the myocardium. This study presents a review of ECG features attributable to various infiltrative cardiomyopathies and analyzes the prevalence and overlap of electrocardiographic abnormalities in patients with adjudicated CHF. The study included 573 consecutive CHF patients without severe aortic stenosis, further stratified by LV hypertrophy (LVH) and preserved or decreased LV ejection fraction. Comprehensive ECG analysis revealed at least one ECG abnormality typically associated with infiltrative cardiomyopathies in 95% of patients, and more than one ECG abnormality in 70%. An average number of ECG abnormalities was 2.2 ± 1.2 per patient. There was substantial overlap in ECG abnormalities in individual patients, particularly those attributable to Fabry's disease and hemochromatosis (51.5%) or cardiac amyloidosis (46.1%), and hemochromatosis and cardiac amyloidosis (44.2%). Prevalence of various ECG abnormalities was similar across various patient demographics and co-morbidities, including LVH status and/or history of CAD which did not increase the number of ECG abnormalities (2.155 ± 1.238 vs. 2.228 ± 1.192 in patients without CAD history, p = 0.969). Patients with reduced LV ejection fraction had a higher prevalence of widened QRS and premature ventricular complexes. ECG abnormalities attributable to infiltrative cardiomyopathies are common in heart failure patients, with a significant overlap in findings classically attributed to various infiltrative cardiomyopathies. The presence of LVH and decreased LV ejection fraction do not significantly affect the prevalence of ECG abnormalities.</description><issn>1861-0684</issn><issn>1861-0692</issn><issn>1861-0692</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kctO3jAQhS1Exa28AAvkJZuAb0lsdhWiBQmJTbu2Js6E38iJg-2AeAzemMBPWYzmLL5zNJpDyAln55yx9iIzJo2omFDr1I2uxA454LrhFWuM2P3WWu2Tw5wfGas5k2qP7Eujmkap-oC8XQd0JUUHqffxIcG88Y5CN8U0QvDFY6ZQSvLdUqALSEukfhp8KAmKf0a6NY6vcYayWelLmvDZ4wuFqafzqiHg5HA10ZXwOJVMX3zZUBenB8yfGRuEVOgAPiwJf5IfA4SMx1_7iPz7ff336qa6u_9ze_XrrnJc1rxqAaTWBhoNbVeboTHK9Fwq2bKmNYI7VXdSSNlrxhSqVkiu2aBlZ1jdIrbyiJxtc-cUn5b1Ejv67DAEmDAu2UoueK2NUmJFxRZ1KeaccLBz8iOkV8uZ_ajCbquwaxX2swr7YTr9yl-6Eftvy__fy3cERodK</recordid><startdate>20241028</startdate><enddate>20241028</enddate><creator>Mustafa, Mohammed</creator><creator>White, Casey</creator><creator>Harris, Erin</creator><creator>Tawfellos, George</creator><creator>Oredegbe, Al-Ameen</creator><creator>Torosoff, Mikhail</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2587-2302</orcidid></search><sort><creationdate>20241028</creationdate><title>Electrocardiographic abnormalities attributable to infiltrative cardiomyopathies: review and prevalence in patients with congestive heart failure</title><author>Mustafa, Mohammed ; White, Casey ; Harris, Erin ; Tawfellos, George ; Oredegbe, Al-Ameen ; Torosoff, Mikhail</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1351-7aa3889a68a7b59f6949d13437067921c45b3233d8004e4723180f83b9057ee73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mustafa, Mohammed</creatorcontrib><creatorcontrib>White, Casey</creatorcontrib><creatorcontrib>Harris, Erin</creatorcontrib><creatorcontrib>Tawfellos, George</creatorcontrib><creatorcontrib>Oredegbe, Al-Ameen</creatorcontrib><creatorcontrib>Torosoff, Mikhail</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical research in cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mustafa, Mohammed</au><au>White, Casey</au><au>Harris, Erin</au><au>Tawfellos, George</au><au>Oredegbe, Al-Ameen</au><au>Torosoff, Mikhail</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Electrocardiographic abnormalities attributable to infiltrative cardiomyopathies: review and prevalence in patients with congestive heart failure</atitle><jtitle>Clinical research in cardiology</jtitle><addtitle>Clin Res Cardiol</addtitle><date>2024-10-28</date><risdate>2024</risdate><issn>1861-0684</issn><issn>1861-0692</issn><eissn>1861-0692</eissn><abstract>The electrocardiogram (ECG) is routinely used in patients with suspected infiltrative cardiomyopathies; heart diseases characterized by the abnormal deposition of pathological substances in the myocardium. This study presents a review of ECG features attributable to various infiltrative cardiomyopathies and analyzes the prevalence and overlap of electrocardiographic abnormalities in patients with adjudicated CHF. The study included 573 consecutive CHF patients without severe aortic stenosis, further stratified by LV hypertrophy (LVH) and preserved or decreased LV ejection fraction. Comprehensive ECG analysis revealed at least one ECG abnormality typically associated with infiltrative cardiomyopathies in 95% of patients, and more than one ECG abnormality in 70%. An average number of ECG abnormalities was 2.2 ± 1.2 per patient. There was substantial overlap in ECG abnormalities in individual patients, particularly those attributable to Fabry's disease and hemochromatosis (51.5%) or cardiac amyloidosis (46.1%), and hemochromatosis and cardiac amyloidosis (44.2%). Prevalence of various ECG abnormalities was similar across various patient demographics and co-morbidities, including LVH status and/or history of CAD which did not increase the number of ECG abnormalities (2.155 ± 1.238 vs. 2.228 ± 1.192 in patients without CAD history, p = 0.969). Patients with reduced LV ejection fraction had a higher prevalence of widened QRS and premature ventricular complexes. ECG abnormalities attributable to infiltrative cardiomyopathies are common in heart failure patients, with a significant overlap in findings classically attributed to various infiltrative cardiomyopathies. The presence of LVH and decreased LV ejection fraction do not significantly affect the prevalence of ECG abnormalities.</abstract><cop>Germany</cop><pmid>39466445</pmid><doi>10.1007/s00392-024-02568-2</doi><orcidid>https://orcid.org/0000-0002-2587-2302</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1861-0684
ispartof Clinical research in cardiology, 2024-10
issn 1861-0684
1861-0692
1861-0692
language eng
recordid cdi_proquest_miscellaneous_3121589442
source SpringerNature Journals
title Electrocardiographic abnormalities attributable to infiltrative cardiomyopathies: review and prevalence in patients with congestive heart failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-10T12%3A33%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Electrocardiographic%20abnormalities%20attributable%20to%20infiltrative%20cardiomyopathies:%20review%20and%20prevalence%20in%20patients%20with%20congestive%20heart%20failure&rft.jtitle=Clinical%20research%20in%20cardiology&rft.au=Mustafa,%20Mohammed&rft.date=2024-10-28&rft.issn=1861-0684&rft.eissn=1861-0692&rft_id=info:doi/10.1007/s00392-024-02568-2&rft_dat=%3Cproquest_cross%3E3121589442%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3121589442&rft_id=info:pmid/39466445&rfr_iscdi=true